1 National trends in rates of death and hospital admissions related to acute myocardial infarction, heart failure and stroke, 1994–2004 CIHR Team Grant.

Slides:



Advertisements
Similar presentations
Investigating Gender Differences in HEDIS Measures Related to Heart Disease Ann F. Chou, PhD, MPH Carol S. Weisman, PhD Rosaly Correa-de-Araujo, MD, PhD.
Advertisements

1 CCORT/CCS 2008 Quality Indicators for Acute Myocardial Infarction (AMI) Care - Introduction CIHR Team Grant in Cardiovascular Outcomes Research Jack.
Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction Robert W. Yeh, MD MSc Massachusetts General Hospital Alan S. Go, MD Kaiser.
Ischaemic Heart Disease- Implications of Gender Dr Kaye Birks School of Rural Health Monash University Australia Gender Competency Training for Medical.
1 Trends in risk factors for cardiovascular disease in Canada: Temporal, socio-demographic and geographic factors, 1994–2004 CIHR Team Grant in Cardiovascular.
1 Canadian Institute for Health Information. Health Care in Canada, 2011: A Focus on Seniors and Aging An Overview 2.
K Fox, W Remme, C Daly, M Bertrand, R Ferrari, M Simoons On behalf of the EUROPA investigators. The diabetic sub study of.
Primary care of hypertensive patients and the risk of acute events Irina Stirbu-Wagner Markus MJ Nielen Maaike Langelaan Robert A. Verheij Joke C. Korevaar.
“ Age-Related Differences in Characteristics, Performance Measures, Treatment Trends, and Outcomes in Patients with Ischemic Stroke ” Gregg C. Fonarow,
1 Women & Heart Disease Julia C. Orri, Ph.D. Biol. 330 November 21, 2006.
The ONTARGET Trial Reference The ONTARGET investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:15.
Reference Cooper BA, and the IDEAL study group. A randomized controlled trial of early versus late initiation of dialysis. N Engl J Med [Accessed.
Epidemiology of Stroke Dexter L. Morris, PhD, MD Department of Emergency Medicine University of North Carolina School of Medicine Chapel Hill, NC.
Population Health Research Institute Hamilton Health Sciences/McMaster University Hamilton, Canada Steroids In caRdiac Surgery (SIRS) Trial SIRS was funded.
1 Canadian Institute for Health Information. Hospital Care for Heart Attacks Among First Nations, Inuit and Métis Released January 31,
Quality of Care and Outcomes in Patients with Diabetes Hospitalized with Ischemic Stroke Findings From Get With The Guidelines-Stroke Reeves MJ; Vaidya.
Diabetes Trials Unit University of Oxford WebSite: Lipids in Diabetes Study.
Asthma Prevalence in Canada Population aged 12 and older who reported that they have been diagnosed by a health professional as having asthma. Source:
National Report Card on Hospital care for heart disease in Indigenous Australia Traven Lea, National Manager, Aboriginal and Torres Strait Islander Program.
Description of fracture with endocrine therapy use in older breast cancer survivors in a population-based setting Taryn Becker 123, Geoff Anderson 123,
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
CHAPTER 24: Converging Issues in Heart Disease, Stroke, and Alzheimer’s Disease in Women.
CARDIOVASCULAR DISEASE National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
Inequalities in coronary heart disease treatment Professor Azeem Majeed University College London.
Clinical implications. Burden of coronary disease 56 millions deaths worldwide in millions deaths worldwide in % due to CV disease (~ 16.
Cardiovascular Morbidity Following Modern Treatment for Hodgkin Lymphoma: Age- and Sex- Specific Estimates of Risk in the Doxorubicin Era. D. Hodgson 1,
Cardiovascular Disease in Women Module I: Epidemiology.
Cardiovascular Disease in Women Module V: Prognosis and Treatment Outcomes.
Canadian Cardiovascular Outcomes Research Team A Canadian Institutes of Health Research - Heart and Stroke Foundation of Canada Interdisciplinary.
Informing Public Policy to Address Health Care Disparities Boisey Barnes, MD, F.A.C.C. Founding Member and Trustee Association of Black Cardiologists.
Chiu et al., CMAJ 2010 Do ethnic groups living in Ontario differ in their cardiovascular risk profiles? Maria Chiu, MSc, PhD Candidate Inst. of Medical.
By Judith Graham heart-attacks/ The Deadly Threat of Silent Heart Attacks.
1 CCORT/CCS 2008 Quality Indicators for Acute Myocardial Infarction (AMI) Care-Indicator Definitions CIHR Team Grant in Cardiovascular Outcomes Research.
1 EFFECT STUDY 2 EFFECT STUDY  Set national cardiac care benchmarks for hospitals to work towards 
Socio-economic gradients in the occurrence of stroke and 30 days in- hospital mortality after a stroke in Canada 2014 Canadian Population Health Association.
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Trial MEGA Trial Presented at The American Heart Association.
Experience in Other Provinces: Nova Scotia Stroke System Neala Gill, RN, BN, MA Cardiovascular Health Nova Scotia Quebec Summit on Stroke October 7, 2008.
Increasing rates of angioplasty versus bypass surgery in Canada, CIHR Team Grant in Cardiovascular Outcomes Research From the CCORT Investigators.
Cardiac Rehabilitation 2011 Update for Primary Care Providers Douglass A Morrison, MD, PhD Cardiac Rehabilitation, Medical Director Yakima Regional and.
AIRE: Acute Infarction Ramipril Efficacy study Purpose To determine whether the ACE inhibitor ramipril reduces mortality in patients with evidence of heart.
Relationship between total cholesterol and 90-day mortality after acute myocardial infarction in patients not on statins Rishi Parmar 2 nd year Medicine.
Elizabeth Ofili, M.D., M.P.H., F.A.C.C. Professor of Medicine and Chief of Cardiology Director, Clinical Research Center Associate Dean of Clinical Research.
HOPE: Heart Outcomes Prevention Evaluation study Purpose To evaluate whether the long-acting ACE inhibitor ramipril and/or vitamin E reduce the incidence.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
Safer Healthcare Now! Acute Myocardial Infarction Presented by Amanda Thompson, Safer Healthcare Now Facilitator.
Polypill x Aspirin Project Groups 3 and 4
Clinical Trial Results. org Characteristics, Management, and Outcomes of 5,557 Patients Age ≥90 Years With Acute Coronary Syndromes: Results From the CRUSADE.
Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial PEACE Trial Presented at The American Heart Association Scientific Sessions.
4S: Scandinavian Simvastatin Survival Study
Long-term mortality and thrombolysis therapy after a first acute ischemic stroke: gender differences. Ebrictus II Study. Authors & Affiliations Clua-Espuny.
Rosuvastatin 10 mg n=2514 Placebo n= to 4 weeks Randomization 6weeks3 monthly Closing date 20 May 2007 Eligibility Optimal HF treatment instituted.
Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.
The MICRO-HOPE. Microalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation Reference Heart Outcomes Prevention Evaluation.
The JUPITER Trial Reference Ridker PM. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Flow Diagram of the Trial Selection Process Jeffrey S. Berger et al, JAMA. 2006;295:
** KIM Division of Chronic Disease Control, Korea Centers for Disease Control and Prevention Study on a Pre-hospital project of Republic of Korea (ROK)-type.
Angela Aziz Donnelly April 5, 2016
for the CCORT/CCS AMI Quality Indicator Panel
The IDEAL Study Reference
Andre Lamy on behalf of the COMPASS Investigators
Cardiovascular Disease (CVD) in Texas
European Heart Association Journal 2007 April
Sex Differences in Clinical Profiles and Quality of Care Among Patients With ST‐Segment Elevation Myocardial Infarction From 2001 to 2011: Insights From.
LRC-CPPT and MRFIT Content Points:
Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact  Jack V. Tu, MD, PhD, Anam M. Khan,
Ongoing statin therapy at hospitalization for acute myocardial infarction. Learnings for general practitioners. Ghena Shabana Specialist in Family Medicine.
The Heart Truth Delaware Background
Cases of and deaths from cervical cancer, with associated incidence and mortality (rates per women), among Canadian women (2002–2006) by age group.
Many post-MI patients are not receiving optimal therapy
Presentation transcript:

1 National trends in rates of death and hospital admissions related to acute myocardial infarction, heart failure and stroke, 1994–2004 CIHR Team Grant in Cardiovascular Outcomes Research Jack V. Tu MD PhD, Lorelei Nardi MSc, Jiming Fang PhD, Juan Liu MD, Laila Khalid MD, Helen Johansen PhD, for the Canadian Cardiovascular Outcomes Research Team

CCORT CCORT is a group of over 30 outcomes researchers from 5 provinces (NS, QC, ON, AB, BC) who are working together on projects to measure and improve the quality of cardiac care in Canada Funded by a CIHR Team Grant in Cardiovascular Outcomes Research Institute for Clinical Evaluative Sciences (ICES) in Toronto is the national coordinating centre for CCORT CIHR Team Grant in Cardiovascular Outcomes Research

Purpose of Study To examine national trends between 1994 and 2004, in hospitalizations and death rates for acute myocardial infarction, heart failure and stroke To see whether the rate of change for these three conditions has been similar or different CIHR Team Grant in Cardiovascular Outcomes Research

Methods We analyzed mortality data from Statistic Canada’s Canadian Mortality Database and data on hospital admissions from the Canadian Institute for Health Information’s Hospital Morbidity Database for the period We determined age- and sex-standardized rates of death and hospital admissions per 100,000 population aged 20 years and over as well as in-hospital case- fatality rates CIHR Team Grant in Cardiovascular Outcomes Research

Overview The following is a set of slides that highlight key findings from the original manuscript including the following: – Decrease in mortality rates – Decrease in hospital admission rates – Decrease in in-hospital case-fatality rates – Differences between men and women in relation to mortality and hospitalization rates Please feel free to use these slides to disseminate this information CIHR Team Grant in Cardiovascular Outcomes Research

Trends in the rates of death, hospital admissions and in-hospital case fatality associated with acute myocardial infarction, heart failure and stroke in Canada,

Age- and sex-specific rates of death by cardiovascular disease per 100,000 population aged 20 and over in Canada,

Age- and sex-standardized rates of death from acute myocardial infarction, heart failure and stroke per 100,000 population aged 20 and over in Canada, Rates are standardized to the Canadian 1991 census population

38.1 % 23.5 % 28.2 %

32.3% 27.5% 32.3%

Age- and sex-standardized rates of hospital admissions because of acute myocardial infarction, heart failure and stroke per 100,000 population aged 20 and over in Canada, Rates are standardized to the Canadian 1991 census population.

9.2 % 27.2 % 27.6 %

Age- and sex-adjusted in-hospital case-fatality rates among patients with acute myocardial infarction, heart failure and stroke in Canada, Rates are standardized to the Canadian 1991 census population.

33.1 % 8.1% 8.9 %

Age- and sex-specific rates of hospital admissions by cardiovascular disease per 100,000 population aged 20 and over in Canada,

Conclusions Mortality, hospitalization and in-hospital case-fatality rates for heart disease decreased significantly between For the first time in Canada, more women than men died from cardiovascular disease in 2000 Efforts to prevent cardiovascular disease have been successful but may have delayed the onset of disease until people are older Further prevention, treatment and national surveillance of cardiovascular disease is continuously required as it is still the leading cause of death in Canada

Reasons for mortality decline Better heart disease prevention – Decreasing smoking rates – Greater awareness and control of hypertension – Decreasing cholesterol levels (i.e. statins) Better heart disease treatment – Aspirin, beta-blockers, ACE inhibitors, statins, etc. – Fibrinolytics (clot-busting drugs), – Primary angioplasty, CABG surgery

Funding This study was supported by a Team Grant in Cardiovascular Outcomes Research to the Canadian Cardiovascular Outcomes Research Team from the Canadian Institutes of Health Research CIHR Team Grant in Cardiovascular Outcomes Research

Thank You For more information please visit CIHR Team Grant in Cardiovascular Outcomes Research